High Chair Safety Standards Approved by CPSC

Federal safety officials have voted unanimously to pass new standards for high chairs, in an effort to reduce the risks of children falling from the seats and suffering injuries. 

The U.S. Consumer Product Safety Commission (CPSC) announced the mandatory high chair standards on June 12, requiring increased rearward stability, warning labels, and requiring chairs to have passive crotch restraints, as well as a three-point restraint system.

The action comes after a review of high chair-related accident reports, which involved a total of 271 injuries reported between January 2011 and September 2017. Most of the problems occurred due to infants tipping over, or falling out of the chairs because they were not harnessed in the seat, or tray tables detached, allowing the child to fall forward. More than 18,000 high chair injuries were recorded between 2015 and 2016.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Most of the injuries observed in the incident reports resulted from a child attempting to climb into or out of the high chair. Other scenarios included the high chair tipping over after the child pushed back or rocked back and forth while seated in the chair. Officials identified other injury reasons stemmed from high chair device failures including faulty restraints or locking mechanism failures.

The new standards will require manufacturers to increase the rearward stability of high chairs to make them less vulnerable to tipping over if a child rocks back and forth. Addition requirements include a three point restraint system to prevent children from climbing out of the seats, and a passive crotch restraint that will not let children slip out from under the seat if restraint system were to fail.

The standards were introduced by the American Society for Testing and Materials (ASTM) as voluntary standards for manufacturers under ASTM F404-18, Standard Consumer Safety Specification for High Chairs. However, the CPSC is adopting these standards as a mandatory feature for all high chairs sold in the U.S. market, and for restaurants that offer high chairs to customers.

The CPSC stated the new mandatory high chair standards will go into effect 12 months after the final rule has been published in the Federal Register. From that date, the rules will apply to all manufacturers, distributors and importers.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay
Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay (Posted today)

Kentucky man has filed a lawsuit against Suboxone manufacturers, indicating the opioid treatment film strips were known for years to cause the kind of permanent tooth damage he suffered, long before warning labels were added by the drug manufacturer.

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL
Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 3 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted 4 days ago)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.